- Filed
- Jul 30, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Jul 23, 2024 | 971.06K sh |
| Long Term Debt | Q2 2024 · Jun 29, 2024 | $992M |
| Long Term Debt | Q2 2024 · Dec 31, 2023 | $997M |
| Short Term Investments | Q2 2024 · Jun 29, 2024 | $1.07B |
| Short Term Investments | Q2 2024 · Dec 31, 2023 | $973M |
| Cash And Equivalents | Q2 2024 · Jun 29, 2024 | $79M |
| Cash And Equivalents | Q2 2024 · Dec 31, 2023 | $56M |
| Stockholders Equity | Q2 2024 · Jun 29, 2024 | $4.7B |
| Stockholders Equity | Q2 2024 · Dec 31, 2023 | $4.62B |
| Current Liabilities | Q2 2024 · Jun 29, 2024 | $1.43B |
| Current Liabilities | Q2 2024 · Dec 31, 2023 | $1.34B |
| Total Liabilities | Q2 2024 · Jun 29, 2024 | $2.99B |
| Total Liabilities | Q2 2024 · Dec 31, 2023 | $2.93B |
| Current Assets | Q2 2024 · Jun 29, 2024 | $3.5B |
| Current Assets | Q2 2024 · Dec 31, 2023 | $3.36B |
| Total Assets | Q2 2024 · Dec 31, 2023 | $7.57B |
| Shares Diluted | Q2 2024 · Jul 1, 2023 | 1.16M sh |
| Shares Diluted | Q2 2024 · Jul 1, 2023 | 1.16M sh |
| Dividends Paid | Q2 2024 · Jul 1, 2023 | $5M |
| Capex | Q2 2024 · Jul 1, 2023 | $219M |
| Operating Cash Flow | Q2 2024 · Jul 1, 2023 | $204M |
| Eps Diluted | Q2 2024 · Jul 1, 2023 | $44.80 |
| Eps Diluted | Q2 2024 · Jul 1, 2023 | $31.01 |
| Eps Basic | Q2 2024 · Jul 1, 2023 | $44.80 |
| Eps Basic | Q2 2024 · Jul 1, 2023 | $31.01 |
| Sga Expense | Q2 2024 · Jul 1, 2023 | $100M |
| Sga Expense | Q2 2024 · Jul 1, 2023 | $197M |
| Operating Income | Q2 2024 · Jul 1, 2023 | −$4M |
| Operating Income | Q2 2024 · Jul 1, 2023 | −$67M |
| Gross Profit | Q2 2024 · Jul 1, 2023 | $96M |
| Gross Profit | Q2 2024 · Jul 1, 2023 | $130M |
| Revenue | Q2 2024 · Jul 1, 2023 | $2.39B |
| Revenue | Q2 2024 · Jul 1, 2023 | $4.89B |